CH370076A - Verfahren zur Herstellung neuer jodierter Säureamide - Google Patents

Verfahren zur Herstellung neuer jodierter Säureamide

Info

Publication number
CH370076A
CH370076A CH6814159A CH6814159A CH370076A CH 370076 A CH370076 A CH 370076A CH 6814159 A CH6814159 A CH 6814159A CH 6814159 A CH6814159 A CH 6814159A CH 370076 A CH370076 A CH 370076A
Authority
CH
Switzerland
Prior art keywords
acid amides
hydroxyl group
production
formula
diiodo
Prior art date
Application number
CH6814159A
Other languages
German (de)
English (en)
Inventor
Habicht Ernst Dr Phil
Original Assignee
Cilag Chemie Aktiengesellschaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilag Chemie Aktiengesellschaf filed Critical Cilag Chemie Aktiengesellschaf
Priority to CH6814159A priority Critical patent/CH370076A/de
Priority to DEC20330A priority patent/DE1097084B/de
Priority to AT916359A priority patent/AT216139B/de
Priority to US862473A priority patent/US2995561A/en
Priority to ES0254772A priority patent/ES254772A1/es
Priority to NL247111A priority patent/NL120495C/xx
Priority to NL247111D priority patent/NL247111A/xx
Priority to GB809/60A priority patent/GB886094A/en
Publication of CH370076A publication Critical patent/CH370076A/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
CH6814159A 1959-01-09 1959-01-09 Verfahren zur Herstellung neuer jodierter Säureamide CH370076A (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CH6814159A CH370076A (de) 1959-01-09 1959-01-09 Verfahren zur Herstellung neuer jodierter Säureamide
DEC20330A DE1097084B (de) 1959-01-09 1959-12-11 Roentgenkontrastmittel
AT916359A AT216139B (de) 1959-01-09 1959-12-17 Röntgenkontrastmittel
US862473A US2995561A (en) 1959-01-09 1959-12-29 Certain nu-(3, 5-diiodo-4-pyridonealkanoyl)-aminoalkanoic acids
ES0254772A ES254772A1 (es) 1959-01-09 1960-01-05 Procedimiento para la obtencion de preparados contrastantes para rayos x
NL247111A NL120495C (US06534493-20030318-C00166.png) 1959-01-09 1960-01-07
NL247111D NL247111A (US06534493-20030318-C00166.png) 1959-01-09 1960-01-07
GB809/60A GB886094A (en) 1959-01-09 1960-01-08 Novel diiodo-pyridones and compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH6814159A CH370076A (de) 1959-01-09 1959-01-09 Verfahren zur Herstellung neuer jodierter Säureamide

Publications (1)

Publication Number Publication Date
CH370076A true CH370076A (de) 1963-06-30

Family

ID=4528494

Family Applications (1)

Application Number Title Priority Date Filing Date
CH6814159A CH370076A (de) 1959-01-09 1959-01-09 Verfahren zur Herstellung neuer jodierter Säureamide

Country Status (7)

Country Link
US (1) US2995561A (US06534493-20030318-C00166.png)
AT (1) AT216139B (US06534493-20030318-C00166.png)
CH (1) CH370076A (US06534493-20030318-C00166.png)
DE (1) DE1097084B (US06534493-20030318-C00166.png)
ES (1) ES254772A1 (US06534493-20030318-C00166.png)
GB (1) GB886094A (US06534493-20030318-C00166.png)
NL (2) NL120495C (US06534493-20030318-C00166.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3235461A (en) * 1966-02-15 Esters of j,s-diiodo-x-pyridone-n- acetic acid
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
NL131733C (US06534493-20030318-C00166.png) * 1961-06-20
FR123F (US06534493-20030318-C00166.png) * 1963-10-17 1900-01-01
CA1225585A (en) * 1983-06-30 1987-08-18 Maria T. Litvinova Composition for embolization of blood vessels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2064944A (en) * 1930-12-20 1936-12-22 Winthrop Chem Co Inc Pyridine derivatives and process of making them
US2505634A (en) * 1947-10-03 1950-04-25 Sterling Drug Inc 4-pyridone-nu-carboxylic acids
US2606922A (en) * 1949-12-03 1952-08-12 Schering Corp Etherified phenyl aliphatic acids and their salts

Also Published As

Publication number Publication date
US2995561A (en) 1961-08-08
GB886094A (en) 1962-01-03
AT216139B (de) 1961-07-10
DE1097084B (de) 1961-01-12
ES254772A1 (es) 1960-08-16
NL120495C (US06534493-20030318-C00166.png) 1965-12-15
NL247111A (US06534493-20030318-C00166.png) 1964-02-10

Similar Documents

Publication Publication Date Title
CH370076A (de) Verfahren zur Herstellung neuer jodierter Säureamide
DE2900506C2 (US06534493-20030318-C00166.png)
CH345016A (de) Verfahren zur Herstellung von p-Oxy-phenylamiden
DE2143720C3 (de) Verfahren zur Herstellung von reinem DL-Tryptophan
DE2301358A1 (de) Vergahren zur herstellung von hydroxyl-prolin und n-acetyl-hydroxy-l-prolin
AT239778B (de) Verfahren zur Herstellung von neuen Phenylalaninderivaten und ihren Salzen
AT210431B (de) Verfahren zur Herstellung von neuen Guanidinverbindungen
AT204049B (de) Verfahren zur Herstellung von neuen Pyridazinderivaten
EP1339697B1 (de) Verfahren zur herstellung von phenylen-bis-benzimidazol-tetrasulfonsäure-dinatriumsalz
AT210064B (de) Röntgenkontrastmittel
CH317294A (de) Verfahren zur Herstellung einer therapeutisch wertvollen Rhodanverbindung
DE1113696B (de) Verfahren zur Herstellung 1,3-disubstituierter oder 1,3,8-trisubstituierter 9-Methylisoxanthine
CH392552A (de) Verfahren zur Herstellung von Oxyxanthonderivaten
CH269401A (de) Verfahren zur Darstellung eines basischen Äthers.
DE1013643B (de) Verfahren zur Herstellung von therapeutisch wertvollen Salicylsaeureamidaethern
CH264292A (de) Verfahren zur Herstellung eines Acylessigsäureamides.
CH369459A (de) Verfahren zur Herstellung von 5-Fluor-uracil
DE1005528B (de) Verfahren zur Herstellung von 1-Phenyl-2-amino-1, 3-propandiolen oder deren 2-N-Acyl-erivaten
DE1284962B (de) Verfahren zum Reinigen von unreinen symmetrischen Diarylketoncarbonsaeuren
CH247927A (de) Verfahren zur Darstellung eines basischen Esters einer 1-Aryl-cycloalkyl-1-carbonsäure.
CH282938A (de) Verfahren zur Darstellung von d,1-N-Acetyl-norvalin.
DE2429317A1 (de) 1-phenyl-4-chlor-5(p--aminobenzolsulfonil)-aminopyrazol und verfahren zu seiner herstellung
CH400164A (de) Verfahren zur Herstellung von 3-Methoxy-2-sulfapyrazin
CH338452A (de) Verfahren zur Herstellung von Amiden von N-Alkyl-piperidin-monocarbonsäuren und N-Alkyl-pyrrolidin-s-monocarbonsäuren
DE1111194B (de) Verfahren zur Herstellung des Piperazinsalzes der N-Acetyl-ª‡-aminoisocapronsaeure